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A 7-week-old girl presented with disseminated stage 4 neuroblastoma complicated with massive he-
patomegaly and signs of liver failure. She underwent wedge liver biopsy and decompressive laparotomy
with GORE-TEX patch placement prior to the administration of chemotherapy. Her ﬂuid losses during
chemotherapy were so severe that her GORE-TEX patch became tense and ﬁlled with ascites resulting in
abdominal compartment syndrome (ACS). A negative pressure dressing system was applied after
opening the patch to assist in the quantiﬁcation of the ﬂuid losses and to allow decompression. Un-
fortunately, in spite of favorable histology, the patient failed to adequately respond to chemotherapy
resulting in persistent hepatomegaly. Soon after, she developed respiratory, renal insufﬁciency and
disseminated intravascular coagulation, leading to her death 12 days after the initiation of treatment.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Neuroblastoma is the most common extracranial solid malig-
nancy in infancy with a wide spectrum of severity ranging from
spontaneous regression to metastatic dissemination culminating in
death. The prevalence is about 1 case per 7000 live births [1]. The
International Neuroblastoma Staging System (INSS) is used to
classify the extent of disease [2,3]. Stage 4 neuroblastoma is deﬁned
as dissemination of neuroblastoma to distant lymph nodes, bone,
skin, liver and/or other organs. Patientswho are under 12months of
age with localized neuroblastoma (stage 1 or 2) are placed into a
speciﬁc subtype of stage 4 known as stage 4S [2]. We are presenting
a case of abdominal compartment syndrome due to tumor lysis
syndrome in a patient with disseminated stage 4 neuroblastoma
who was already treated with decompressive laparotomy. This is
the ﬁrst reported case of secondary Abdominal Compartment
Syndrome (ACS) in a patient who already underwent decom-
pressive laparotomy.Surgery, Nicklaus Children’s




a, FL 33607, USA.
Inc. This is an open access article u1. Case
A 7-week-old female infant presented to our ER with a 2-week
history of abdominal distention. A bone marrow biopsy at her
native country revealed cells being suspicious of malignancy. On
arrival, examination revealed massive hepatomegaly with abdom-
inal distention. Abdominopelvic computed tomography (CT) scan
showed bilateral suprarenal masses (left larger than right) and
multiple hepatic nodules with hepatomegaly (Fig.1). These ﬁndings
were consistent with disseminated stage 4 neuroblastoma. In
anticipation of secondary ACS and tumor lysis syndrome after
chemotherapy we proceeded with prophylactic decompressive
laparotomy. A transverse abdominal incision was performed
extending to both iliac crests. At laparotomy, a left suprarenal mass
and hepatomegaly with metastasis were identiﬁed (Fig. 2). Two
large GORE-TEX patches (20  30 cm) were sutured to the fascia
from inferior and superior aspects and shaped as a parachute to
allow for expansion of the liver.
The initial chemotherapy protocol for high-risk neuroblastoma
was initiated soon after decompressive laparotomy. Her ﬂuid losses
during chemotherapy were so severe that her GORE-TEX patch
progressively became tense and ﬁlled with ascites resulting in
secondary abdominal compartment syndrome 10 days after her
initial surgery. The patient developed respiratory failure requiring
increasing peak pressures, acute renal failure and disseminated
intravascular coagulation. On post-operative day number 10, shender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Stage 4 neuroblastoma, bilateral suprarenal masses with multiple hepatic
nodules and hepatomegaly.
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arotomy. Fig. 3 demonstrates the patient’s tense abdomen prior to
her second decompressive laparotomy.
Open Abdomen Negative Pressure Therapy System (ABThera)
was placed after opening the patch to assist in the quantiﬁcation of
the ﬂuid losses and to allow decompression. Immediate improve-
ment was observed in the ventilation and renal function. TheFig. 2. Hepatomegaly with metastatic neuroblastoma.patient had approximately 1600 ml of ascitic ﬂuid per 24 h being
collected by the ABTHera. This technique facilitated with the ﬂuid
resuscitation during tumor lysis syndrome. Unfortunately, even
though she had favorable histology, her liver had increased in size
after the ﬁrst round of chemotherapy. Forty eight hours after
decompression, she developed multisystem organ failure and
became anuria, suffering a cardiac arrest during an emergent
bedside hemodialysis catheter placement.
2. Discussion
The treatment for neuroblastoma varies greatly secondary to a
wide spectrum of clinical presentations ranging from spontaneous
regression to an aggressive form resulting in death. The Interna-
tional Neuroblastoma Risk Group (INRG) system stratiﬁes neuro-
blastoma into various pre-treatment risk groups depending on age,
imaging, tumor histology, the presence or absence of MYC gene
ampliﬁcation, chromosomal changes and DNA ploidy [3,4].
The World Society of the Abdominal Compartment Syndrome
(WSACS) deﬁnes ACS in adults as sustained intra-abdominal pres-
sure (IAP) of 20 mm Hg (with or without abdominal perfusion
pressure <60 mm Hg) that is associated with a new organ
dysfunction/failure. In the pediatric population, ACS is deﬁned as a
sustained elevation in IAP of greater than 10mmHg associatedwith
a new or worsening organ dysfunction that can be attributed to
elevated IAP [5]. ACS can be classiﬁed as primary or secondary [6].
Primary ACS is characterized by elevation of IAP secondary to intra-
abdominal etiology such as trauma, liver transplantation, retro-
peritoneal hemorrhage and ruptured abdominal aortic aneurysm.
Secondary ACS characterized by elevation of IAP as a result of extra-
abdominal etiology such as major burns, capillary leak, or other
conditions requiring massive ﬂuid resuscitation [7]. Despite pro-
phylactic decompressive laparotomy, our patient with dissemi-
nated neuroblastoma developed secondary ACS with IAP of
19 mm Hg and an abdominal perfusion pressures of 51 mm Hg. She
experienced signiﬁcant ﬂuid losses during chemotherapy and
developed renal and respiratory failure.Fig. 3. The GORE-TEX patches (20  30 cm) sutured in place for elective decom-
pression required re-opening due to massive ascites associated to tumor lysis syn-
drome and worsening hepatomegaly.
G.V. Klimovich et al. / J Ped Surg Case Reports 4 (2016) 46e4848There is a limited reported experience on management of ACS
secondary to disseminated stage 4 neuroblastoma with massive
hepatomegaly. McGahren et al. described a successful utilization
of a prosthetic SILASTIC silo after initial decompressive lapa-
rotomy in a patient with hepatomegaly secondary to 4S neuro-
blastoma. In order to decrease the likelihood of an infection, the
silo was replaced with absorbable Vicryl mesh after 12 days [8].
There are three additional cases that have been described in
literature in which negative pressure dressing was applied suc-
cessfully for wound healing and removal of excess intra-
abdominal ﬂuid after abdominal decompression in patients with
4S neuroblastoma [9,10]. In our case, patient developed second-
ary ACS despite initial decompressive laparotomy and placement
of GORE-TEX patch to allow additional expansion. This is the
ﬁrst reported case of ACS in a neonatal patient with disseminated
neuroblastoma who had already undergone laparotomy. During
our second decompressive laparotomy, we placed the Open
Abdomen Negative Pressure Therapy System (ABThera). This
system enabled us to decompress the abdomen and to quantify
the ﬂuid losses secondary to chemotherapy-induced tumor lysis
syndrome.3. Conclusion
ACS can still develop in patients with stage 4 neuroblastoma
despite decompressive laparotomy and a patch placement allowing
for additional intra-abdominal expansion. Fluid losses can be very
severe, greater than 1600 ml per 24 h, in patients undergoing
chemotherapy during the treatment of disseminated stage 4 neu-
roblastoma with massive hepatomegaly. ABThera is an excellent
adjunct for patient’s ﬂuid management in such cases.Conﬂicts of interest
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